Valeant Pharmaceuticals/Bill Ackman E-mails

Released yesterday.

Highlights:

Halt the Stock
Send out a Press Release
Advice on Conference Call
Don't speak with the media
Rome is burning

Crossposting, credits to humanafteralll from WSB.

Attachment Size
Halt the Stock 57.91 KB 57.91 KB
Send out a Press Release 115.64 KB 115.64 KB
Advice on Conference Calls 118.77 KB 118.77 KB
Don't Speak With the Media 115.11 KB 115.11 KB
Rome is Burning 160.01 KB 160.01 KB
Region
 

there is no date on the last email, but if Ackman thinks that Valeant is dead then whats with all the BS in the latest investor presentation about how Valeant will come back to life via appointing Joe Papa as a new CEO

You killed the Greece spread goes up, spread goes down, from Wall Street they all play like a freak, Goldman Sachs 'o beat.
 
Arti:

there is no date on the last email, but if Ackman thinks that Valeant is dead then whats with all the BS in the latest investor presentation about how Valeant will come back to life via appointing Joe Papa as a new CEO

He has an exorbitant portion of his entire fund invested in Valeant. In addition, there aren't any willing buyers for VRX. He's desperate to shore up support for the company because there's no way out.

On another note, John Hempton of Bronte Capital has been killing him on VRX from the beginning. http://brontecapital.blogspot.com.au/2016/05/if-someone-disagrees-with-…

 

There is a way, admit that you are wrong, sell/restructure and move on. Position is 13% from the funds total value, not the largest one, and after the stock collapsed it's even less. Hempton was not the only one dissing VRX, it was pretty much on everyone's tongue after the Citron's report.

You killed the Greece spread goes up, spread goes down, from Wall Street they all play like a freak, Goldman Sachs 'o beat.
 

Yes, it is. These are pulled directly from a US Senate PDF titled, "Valeant Pharmaceutical's Business Model: The Repercussions for Patients and the Health Care System". It's an 818 pg document including all of the above e-mails and analysis of Valeant.

DL: senaging.app.boxDotcom/s/0853lykekrlogev4uuwma6md7hdb97z0

78mb PDF. Page 483.

Apologies for the broken link for being a new user; just add https:// and dot. Hope this helps.

 
Best Response
couchy:

VRX is really just a company full of consultants with no R&D pipeline - all they do is acquire and cut costs. But cutting out marketing for pharma just reduces your next wave of revenues so the earnings quality is shit. They basically think they can take the R&D risk out of the biopharma model and aren't the first to try it. Other big pharma companies eventually got slammed - the only difference is vrx is catching themselves earlier before the fall.

IMO vrx needs agn more than the other way around - they also need ackmann more than ackmann needs them. i wouldn't touch vrx until they build themselves into a legitimate research house (doubtful although this deal is kind of a move toward that direction) because vrx can't play this acquisition game forever. Pharma is about landing homeruns, not walking to first base. big risks big rewards.

http://www.wallstreetoasis.com/blog/ackman-teaming-with-valeant-to-take…

 

They've announced a pretty late date for releasing Q1 earnings also. They said in their announcement that it will still be released "well ahead of the hard deadline before we default" or something like that. Dude that's not a bragging point...how hard is it to release earnings? I still find the delay on the Q4 2015 earnings report bizarre.

 

13-Fs became public today for 3/31 period. Tons of big name holders completely blew out of VRX: Brahman, Viking, Lone Pine, Grantham, Brave Warrior, Janus, Coatue.... including TRowe here because they sold an impressive 20mm shares and were the #3 holder. There were a couple additions but more rampant selling for sure.

Talk about capitulating on VRX... not verified but just optically seeing a lot of HF roll-up investors took down exposure / sold roll-up positions. Obviously VRX is the ultimate roll-up blowup but just thought it was interesting that HFs are taking a more conservative approach to the roll-up names

 

Repudiandae exercitationem dolor quibusdam ut aut. Hic ea animi maxime nostrum sint aut adipisci consequatur. Et et nisi et nihil harum. Ea sit et maxime tempora. Officiis ut autem voluptates dolorum vero. Amet temporibus odit velit et in amet tempore. Ad eos qui ea quos praesentium provident perspiciatis tempore.

Aperiam quae vel eum illo possimus accusantium dolor. Quo repudiandae magnam nesciunt nihil suscipit.

I'm talking about liquid. Rich enough to have your own jet. Rich enough not to waste time. Fifty, a hundred million dollars, buddy. A player. Or nothing. See my Blog & AMA

Career Advancement Opportunities

March 2024 Hedge Fund

  • Point72 98.9%
  • D.E. Shaw 97.9%
  • Magnetar Capital 96.8%
  • Citadel Investment Group 95.8%
  • AQR Capital Management 94.7%

Overall Employee Satisfaction

March 2024 Hedge Fund

  • Magnetar Capital 98.9%
  • D.E. Shaw 97.8%
  • Blackstone Group 96.8%
  • Two Sigma Investments 95.7%
  • Citadel Investment Group 94.6%

Professional Growth Opportunities

March 2024 Hedge Fund

  • AQR Capital Management 99.0%
  • Point72 97.9%
  • D.E. Shaw 96.9%
  • Citadel Investment Group 95.8%
  • Magnetar Capital 94.8%

Total Avg Compensation

March 2024 Hedge Fund

  • Portfolio Manager (9) $1,648
  • Vice President (23) $474
  • Director/MD (12) $423
  • NA (6) $322
  • 3rd+ Year Associate (24) $287
  • Manager (4) $282
  • Engineer/Quant (71) $274
  • 2nd Year Associate (30) $251
  • 1st Year Associate (73) $190
  • Analysts (225) $179
  • Intern/Summer Associate (22) $131
  • Junior Trader (5) $102
  • Intern/Summer Analyst (249) $85
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
dosk17's picture
dosk17
98.9
6
DrApeman's picture
DrApeman
98.9
7
kanon's picture
kanon
98.9
8
CompBanker's picture
CompBanker
98.9
9
GameTheory's picture
GameTheory
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”